Androgen receptor expression in metastatic adenocarcinoma in females favors a breast primary

BACKGROUND: The differential diagnosis of metastatic mammary adenocarcinoma and adenocarcinomas from other primary sites can be challenging, particularly in tumors that are poorly differentiated and negative for Estrogen/Progesterone receptors (ER/PR). With progression of disease, Androgen receptors...

Descripción completa

Detalles Bibliográficos
Autores principales: Shidham, Vinod B, Komorowski, Richard A, Machhi, Jinobya K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1601970/
https://www.ncbi.nlm.nih.gov/pubmed/17020615
http://dx.doi.org/10.1186/1746-1596-1-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1601970/
https://www.ncbi.nlm.nih.gov/pubmed/17020615
http://dx.doi.org/10.1186/1746-1596-1-34

Ejemplares similares